Browsed by
Author: Member Success

Deka Biosciences Announces Scientific Advisory Board Members

Deka Biosciences Announces Scientific Advisory Board Members

Germantown, MD (November 4, 2021) – Deka Biosciences is pleased to announce the appointment of six new members to its Scientific Advisory Board: Aurélien Marabelle, MD, PhD (Gustave Roussy), Aung Naing, MD, FACP (MD Anderson Cancer Center), Abhishek Tripathi, MD (OU Health Stephenson Cancer Center), Khusru Asadullah, MD (The Charité – Universitätsmedizin Berlin, Dermatological Practice in Potsdam), Hans-Dieter Volk, MD (The Charité – Universitätsmedizin Berlin), and Florin Selaru, MD (John’s Hopkins University). ...  Read more

SYNAPS Dx Announces DISCERN, Minimally Invasive Test for Accurate Diagnosis of Alzheimer’s Disease, Receives First-in-Category PLA Codes

SYNAPS Dx Announces DISCERN, Minimally Invasive Test for Accurate Diagnosis of Alzheimer’s Disease, Receives First-in-Category PLA Codes

ROCKVILLE, Md. – (BUSINESS WIRE)–SYNAPS Dx (SDx), a privately held company focused on the research, development and commercialization of diagnostics for neurodegenerative disorders and conditions, including Alzheimer’s Disease (AD), announces that DISCERN™, the first autopsy-validated, highly accurate, minimally invasive test for the definitive diagnosis of AD versus other forms of non-AD dementias. ...  Read more

Maryland Data Center Firm DataBridge Sites Upgrades Dark Fiber Capacity with Lowest Latency Route Available into Northern VA’s Internet Exchange

Maryland Data Center Firm DataBridge Sites Upgrades Dark Fiber Capacity with Lowest Latency Route Available into Northern VA’s Internet Exchange

Maryland Data Center Firm DataBridge Sites Upgrades Dark Fiber Capacity With Lowest Latency Route Available Into Northern VA’s Internet Exchanges

DF&I has selected DataBridge Sites as its Montgomery County, Maryland Dark Fiber On Ramp for The Ashburn Express Dark Fiber Route. ...  Read more

NFP’s InsurChoice™ Empowers Organizations to Offer Customized Insurance Coverages Directly to Their Employees or Members

NFP’s InsurChoice™ Empowers Organizations to Offer Customized Insurance Coverages Directly to Their Employees or Members

NEW YORK, September 7, 2021 –, a leading insurance broker and consultant providing corporate benefits, property and casualty (P&C), retirement and individual solutions, today introduced InsurChoice, a digital marketplace that provides businesses, membership organizations and strategic partners the opportunity to offer personal insurance solutions to their employees, members and customers. ...  Read more

Adaptive Phage Therapeutics Awarded Additional $8 Million from U.S. Department of Defense for Clinical Advancement of Phage to Address Unmet Needs in Infectious Diseases

Adaptive Phage Therapeutics Awarded Additional $8 Million from U.S. Department of Defense for Clinical Advancement of Phage to Address Unmet Needs in Infectious Diseases

GAITHERSBURG, MD, September 30, 2021 – Adaptive Phage Therapeutics, Inc. (APT), a clinical-stage biotechnology company dedicated to providing therapies to treat infectious diseases, today announced that the Department of Defense (DoD) has awarded the company an additional $8 million for the continued development of bacteriophage therapies (PhageBankTM) for the treatment of infectious diseases. The new funding brings the total contract awarded to APT to $31.2 million. ...  Read more

Supernus Pharmaceuticals To Acquire Adamas Pharmaceuticals For $450 Million

Supernus Pharmaceuticals To Acquire Adamas Pharmaceuticals For $450 Million

ROCKVILLE, Md. and EMERYVILLE, Calif., Oct. 11, 2021 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN) and Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), today announced a definitive agreement for Supernus to acquire Adamas through a tender offer for $8.10 per share in cash (or an aggregate of approximately $400 million), payable at closing plus two non-tradable contingent value rights (CVR) collectively worth up to $1.00 per share in cash (or an aggregate of approximately $50 million), for a total consideration of $9.10 per share in cash (or an aggregate of approximately $450 million). ...  Read more

QIAGEN Receives U.S. Department of Defense Contract to Further Expand Production Capacity for NeuMoDx

QIAGEN Receives U.S. Department of Defense Contract to Further Expand Production Capacity for NeuMoDx

September 30, 2021 04:48 PM Eastern Daylight Time

GERMANTOWN, Md. & HILDEN, Germany–(BUSINESS WIRE)–QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it had won a U.S. government contract to increase the production capacity for consumables used on its NeuMoDx 96 and 288 integrated PCR testing systems, an important step to support laboratory testing as the COVID-19 pandemic continues. ...  Read more

SYNAPS Dx Closes $10 Million Series A Investment

SYNAPS Dx Closes $10 Million Series A Investment

ROCKVILLE, Md.–(BUSINESS WIRE)–SYNAPS Dx (SDx), a privately held company focused on the research, development and commercialization of diagnostics for neurodegenerative disorders and conditions, including Alzheimer’s Disease (AD), announces the close of its Series A $10 million investment, including private equity, individual and family funds, and corporate investors. ...  Read more

Blu Venture Partners Join $9.5 Million Series A for cloudtamer.io

Blu Venture Partners Join $9.5 Million Series A for cloudtamer.io

FULTON, Md.–(BUSINESS WIRE)–cloudtamer.io, the leading automated multi-cloud governance and management solution provider, today announced that it has raised a $9.5 million Series A funding round led by Blue Heron Capital and TDF Ventures, with participation from Blu Venture InvestorsEarly Light Ventures and Gaingels. This funding will be used to expand its sales and marketing operations as well as its engineering team to fuel company growth and bring enhanced cloud governance and management capabilities to market. ...  Read more